Updates are available Correction dated 2017-09-19
Click to view Correction: https://doi.org/10.1038/mp.2017.202
-
Authors
Huckins, L M
,
Hatzikotoulas, K http://orcid.org/0000-0002-4699-3672
Southam, L
Thornton, L M
Steinberg, J
Aguilera-McKay, F
Treasure, J
Schmidt, U
Gunasinghe, C
Romero, A
Curtis, C
Rhodes, D
Moens, J
Kalsi, G
Dempster, D
Leung, R
Keohane, A
Burghardt, R
Ehrlich, S
Hebebrand, J
Hinney, A
Ludolph, A
Walton, E
Deloukas, P http://orcid.org/0000-0001-9251-070X
Hofman, A
Palotie, A
Palta, P
van Rooij, F J A
Stirrups, K
Adan, R
Boni, C
Cone, R
Dedoussis, G
van Furth, E
Gonidakis, F
Gorwood, P http://orcid.org/0000-0003-1845-3676
Hudson, J
Kaprio, J http://orcid.org/0000-0002-3716-2455
Kas, M http://orcid.org/0000-0002-4471-8618
Keski-Rahonen, A
Kiezebrink, K
Knudsen, G-P
Slof-Op 't Landt, M C T
Maj, M
Monteleone, A M
Monteleone, P
Raevuori, A H
Reichborn-Kjennerud, T
Tozzi, F
Tsitsika, A
van Elburg, A
Collier, D A
Sullivan, P F
Breen, G http://orcid.org/0000-0003-2053-1792
Bulik, C M
Zeggini, E
- License Information
-
More Information
Article History
Received: 3 August 2016
Revised: 16 February 2017
Accepted: 17 February 2017
First Online: 25 July 2017
Competing interests
: GB has received grant funding and consultancy fees from Eli Lilly. DD is speaker, consultant or on advisory boards of various pharmaceutical companies, including AstraZeneca, Boehringer, Bristol Myers Squibb, Eli Lilly, 28 Genesis Pharma, GlaxoSmithKline, Janssen, Lundbeck, Organon, Sanofi, UniPharma and Wyeth, and he has unrestricted grants from Lilly and AstraZeneca as director of the Sleep Research Unit of Eginition Hospital (National and Kapodistrian University of Athens, Greece). AK is on the Shire Canada BED Advisory Board. JK is a member of SAB of AssurexHealth Inc (unpaid). ML has received lecture honoraria from Lundbeck, AstraZeneca and Biophausia Sweden, and served as scientific consultant for EPID Research Oy. There exists no other equity ownership, profit-sharing agreements, royalties, or patents. PS is scientific advisor to Pfizer, Inc. JT received an honorarium for speaking at a diabetic conference for Lilly and royalties from a published book. The remaining authors declare no conflicts of interest.
